---
document_datetime: 2025-10-24 15:04:15
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rystiggo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: rystiggo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.7328736
conversion_datetime: 2025-12-29 19:35:46.80099
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rystiggo

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                         |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------|
| Variation type II /  | B.II.f.1 Change in the shelf-life or storage | 18/09/2025                          |                                             | SmPC,                            | The SmPC sections 6.4 and 6.6 have been updated |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000282401                     | conditions of the finished product - B.II.f.1.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |     | Labelling and PL   | to add information on short-term storage conditions/excursion (20 days at room temperature) of the biological medicinal product. The Labelling and PL have been updated accordingly.   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IA / EMA/VR/0000291983 | B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.b Replacement or addition of a supplier - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 25/08/2025 | N/A |                    |                                                                                                                                                                                        |
| Variation type II / EMA/VR/0000271895 | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.4 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data - Accepted Update of sections 4.4 and 4.8 of the SmPC in order to add 'Herpes viral infection' to the list of adverse drug reactions (ADRs) with frequency 'not known', based on new cases of herpes zoster reported in clinical studies and from spontaneous post-marketing in generalised myasthenia gravis (gMG), as well as to add 'Nausea' and 'Vomiting' to the list of ADRs with frequency 'common'. The | 24/07/2025 |     | SmPC and PL        |                                                                                                                                                                                        |
| Article 61(3) / EMA/N/0000269426      | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 08/05/2025 |     | PL                 |                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

| PSUR / EMA/PSUR/0000257792   | - -   | Maintenance   |
|------------------------------|-------|---------------|